| Name | Title | Contact Details |
|---|
Ho Chien Electronic Group Inc is a La Verne, CA-based company in the Computers and Electronics sector.
Tournament Components is a San Carlos, CA-based company in the Computers and Electronics sector.
Cortus is a San Jose, CA-based company in the Computers and Electronics sector.
Cypress Semiconductor Corporation is listed on the Nasdaq stock exchange under the ticker symbol CY. Based in San Jose, California, the company has 7,100 employees worldwide serving more than 30,000 customers. Cypress delivers high-performance, high-quality solutions at the heart of today`s most advanced embedded systems, from automotive, industrial and networking platforms to highly interactive consumer and mobile devices. With a broad, differentiated product portfolio that includes NOR flash memories, F-RAM and SRAM, Traveo™ microcontrollers, the industry`s only PSoC® programmable system-on-chip solutions, analog and PMIC Power Management ICs, CapSense® capacitive touch-sensing controllers, and Wireless BLE Bluetooth® Low-Energy and USB connectivity solutions, Cypress is committed to providing its customers worldwide with consistent innovation, best-in-class support and exceptional system value.
Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.